Literature DB >> 5335155

Effects of L-DOPA on pharmacological parkinsonism.

A Bruno, S C Bruno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5335155     DOI： 10.1111/j.1600-0447.1966.tb01931.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  8 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

2.  The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.

Authors:  J Gerlach; K Lühdorf
Journal:  Psychopharmacologia       Date:  1975-10-14

Review 3.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; R Teuflmayr
Journal:  Dtsch Z Nervenheilkd       Date:  1969

5.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Modification of the tremorigenic activity of physostigmine.

Authors:  L M Ambrani; M H Van Woert
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

Review 7.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

Review 8.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.